Richard Manch, MD
Hepatology · Glendale, AZNPI 1043289341
Payments from drug & device makers
Across 1,052 payments — averaging $1152.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intercept Pharmaceuticals, Inc.$432K
- Gilead$218K
- Bausch Health US, LLC$158K
- AbbVie$137K
- Eisai Inc.$46K
- E.r. Squibb & Sons, L.L.C.$44K
- plus $178K from 32 others
Across 9 payments — averaging $129.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few hepatology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hepatology in Glendale
- Ester LittlePhoenix$36K
- Keith LindorScottsdale$19K
- Jinendra SatiyaYuma$945
- Kathia Jusino SuarezChandler$724
- Alberto RamosPhoenix$551
- David TwitchellPhoenix$298
- Geetha KolliPhoenix$219
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.